HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.

AbstractAIMS:
Histopathologists report the presence of neuroendocrine (NE) differentiation in non-small cell lung carcinoma (NSCLC) in up to a third of cases and are often questioned about its clinical relevance. The conclusions of previous studies have been inconsistent. This paper aims to provide an answer by examining a large series together with a comprehensive critique of the literature.
METHODS AND RESULTS:
Four hundred and thirty-nine cases of NSCLC were examined, immunohistochemically, using antibodies to chromogranin A (CGA), synaptophysin (SYN) and CD56/neural cell adhesion molecule (NCAM). Three hundred and forty-one cases had been treated with surgical resection and the remainder with chemotherapy. The results were compared with clinical outcome. Thity-six percent of cases had positive staining for at least one NE marker. CGA was positive in 5.5% of cases, SYN in 16.5% and NCAM in 28%. There was no association between the presence of NE markers and survival in either the surgically treated group or the chemotherapy-treated group. There was also no association between NE markers and response to chemotherapy in the latter group.
CONCLUSIONS:
The presence of immunohistochemically detected NE differentiation in NSCLC is not of prognostic significance.
AuthorsM C Howe, A Chapman, K Kerr, M Dougal, H Anderson, P S Hasleton
JournalHistopathology (Histopathology) Vol. 46 Issue 2 Pg. 195-201 (Feb 2005) ISSN: 0309-0167 [Print] England
PMID15693892 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Chromogranin A
  • Chromogranins
  • Neural Cell Adhesion Molecules
  • Synaptophysin
Topics
  • Adenocarcinoma (metabolism, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Large Cell (metabolism, pathology)
  • Carcinoma, Neuroendocrine (metabolism, pathology)
  • Carcinoma, Non-Small-Cell Lung (metabolism, pathology, therapy)
  • Carcinoma, Squamous Cell (metabolism, pathology)
  • Cell Differentiation
  • Chromogranin A
  • Chromogranins (analysis)
  • Female
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (metabolism, pathology, therapy)
  • Male
  • Middle Aged
  • Neural Cell Adhesion Molecules (analysis)
  • Prognosis
  • Survival Analysis
  • Synaptophysin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: